Immix Biopharma Inc — Dividend History & Yield (NASDAQ:IMMX) | MetaTrader

Open full chart

Financials

Overview Relatórios Statistics Dividends

Quarterly Annual

Dividends per share ———— — Dividend yield % ———— — Payout ratio % ———— —

Notícias

Ações da Immix Biopharma sobem após FDA conceder status de terapia inovadora

FDA concede status de terapia inovadora ao medicamento para amiloidose da ImmixBio

Immix Biopharma stock climbs after FDA grants breakthrough therapy status

FDA grants breakthrough therapy status to ImmixBio’s amyloidosis drug

Immix Biopharma (IMMX) Shares Slip As Investors Focus On Plans To Offer And Sell $750 Million In Securities - Immix Biopharma (NASDAQ:IMMX)

Immix Biopharma: Thesis Playing Out; Thoughts On Valuation And Competition (IMMX)

Diretor financeiro da Immix Biopharma compra US$ 5 mil em ações

CEO da Immix Biopharma, Ilya Rachman, compra ações no valor de US$ 4.975

Immix Biopharma CFO Gabriel Morris buys $5k in shares

Ilya Rachman, Immix Biopharma CEO, buys $4975 in shares

Preço-alvo das ações da Immix Biopharma elevado para US$ 12 de US$ 8 pela H.C. Wainwright

Immix Biopharma stock price target raised to $12 from $8 at H.C. Wainwright